September 12, 2022
Merck Animal Health Launches Nobivac® Intra-Trac® Oral BbPi for Dual Prevention of Two Major Canine Respiratory Pathogens
September 6, 2022
U.S. FDA Approves New Indication for Merck Animal Health’s Bravecto® (fluralaner topical solution) for Cats and Bravecto® Plus (fluralaner and moxidectin topical solution) for Cats
August 2, 2022
Merck Animal Health Extends Support to Next Generation of Poultry Veterinarians: Announces 2022 AAAP Scholarship Recipients
May 17, 2022
Merck Animal Health Donates $500,000 to Texas A&M for New Animal Science Reproduction and Biotechnology Center
May 5, 2022
Merck Animal Health Donates $250,000 to Iowa State University for New Veterinary Diagnostic Laboratory
May 2, 2022
Merck Animal Health Awards $270,000 in Scholarship Support to 54 Veterinary Students in North America
April 26, 2022
Merck Animal Health Launches Innovative Hyper InfusiO2nTM Solutions to Improve Sustainability for Fish and Hydropower
April 19, 2022
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global